Skip to main content


Assessment of Hedgehog/GLI2 signaling inhibitors within metastatic breast cancers

Hedgehog pathway inhibitors were established as potential remediation treatments for tumor-induced bone disease. Additionally, hypotheses concerning inhibition methods were established for future investigation.

Posted by Greta Clinton-Selin on Friday, June 3rd, 2016 in May 2016, , , ,

Read more

Characterization of Novel Drugs that Target the Hedgehog Signaling Pathway in Tumor Induced Bone Disease

This research presents information about optimized transfection conditions for MDA-MB- 231 cells, as well as cell viability data on known antagonists.

Posted by Greta Clinton-Selin on Wednesday, April 29th, 2015 in May 2015, , ,

Read more